Tg Therapeutics (TGTX) FCF Margin (2017 - 2026)
Tg Therapeutics' (TGTX) quarterly FCF Margin came in at 8.76% in Q1 2026, up 1502.0% year-on-year from 0.55% in Q1 2025, and down 186.07% quarter-over-quarter from 10.17% in Q4 2025.
Tg Therapeutics (TGTX) FCF Margin (2017 - 2026) Analysis & Trends
Tg Therapeutics' FCF Margin history runs 10 years deep, the most recent figure standing at 8.76% for Q1 2026.
- On a quarterly basis, FCF Margin rose 1502.0% year-over-year to 8.76% in Q1 2026; TTM through Mar 2026 was 2.03%, a 1379.0% increase from a year earlier, with the FY2025 full-year figure at 4.05%, up 827.0% from the prior year.
- FCF Margin eased to 8.76% in Q1 2026 per TGTX's latest filing, from 10.17% in the prior quarter.
- Across five years, FCF Margin topped out at 50.48% in Q3 2023 and bottomed at 36701.06% in Q3 2022.
- The 5-year median for FCF Margin is 23.72% (2024), against an average of 4664.84%.
- Across the five-year window, FCF Margin tumbled 3338678 bps in 2022 and jumped 3675154 bps in 2023, its largest moves.
- Year by year, FCF Margin stood at 29841.25% in 2022, then soared by 100 bps to 30.04% in 2023, then rose by 21 bps to 23.72% in 2024, then jumped by 143 bps to 10.17% in 2025, then tumbled by 186 bps to 8.76% in 2026.
- Per Business Quant, the three latest TGTX FCF Margin figures stand at 8.76% (Q1 2026), 10.17% (Q4 2025), and 14.37% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | -8.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.76% |
| Dec 31, 2025 | 10.17% |
| Sep 30, 2025 | -14.37% |
| Jun 30, 2025 | 5.24% |
| Mar 31, 2025 | -23.78% |
| Dec 31, 2024 | -23.72% |
| Sep 30, 2024 | -14.58% |
| Jun 30, 2024 | 7.54% |
| Mar 31, 2024 | -12.93% |
| Dec 31, 2023 | -30.04% |
| Sep 30, 2023 | 50.48% |
| Jun 30, 2023 | -261.32% |
| Mar 31, 2023 | -767.68% |
| Dec 31, 2022 | -29,841.25% |
| Sep 30, 2022 | -36,701.06% |
| Jun 30, 2022 | -8,268.69% |
| Mar 31, 2022 | -3,407.54% |
| Dec 31, 2021 | -3,747.91% |
| Sep 30, 2021 | -3,314.29% |
| Jun 30, 2021 | -3,905.76% |